If you're having trouble finding what you're looking for in the MEP and you're a member of the RPS, please contact our Support Team via email at [email protected] or by phone on 0333 733 2570 with what you're looking for.
Signposting and information on the GPhC guidance for registered pharmacies providing pharmacy services at a distance, including the internet.
Added information and signposting to guidance on pharmacists authorising any competent member of the pharmacy team to make the final sale or supply of a ‘checked and bagged medicine’ from 7 January 2026.
Updated guidance on follow up consultations and pregnancy testing as detailed in the MHRA drug safety update on isotretinoin prescribing guidance and survey of services
Included advice from the Neonatal and Paediatric Pharmacists Group (NPPG) that doses of oral liquid medicines should be expressed in terms of millilitres only and signposting to the NPPG guidance Labelling of Dispensed Oral Medicines for Children position statement
Added the requirement to include on a veterinary prescriptions the words "It is an offence under the Veterinary Medicines Regulations 2013 for a person to alter a written prescription unless authorised to do so by the person who signed it."
Information in this section was updated by Pharmacist Support on new services they offer to support and help pharmacists and their families, former pharmacists, trainee pharmacists, MPharm and OSPAP students.
Included Home Office clarification on the 28-day appropriate date validity.
Added signposting and information on the RPS report Medicines Shortages: Solutions for empty shelves.
Updated information and resources.
Emergency supply at the request of a patient: included guidance to help pharmacists ensure duplicate supplies are not made
Updated the list of RPS guidance on reclassified medicines.
Updated to include information and signposting to RPS' position statement and pharmacy guide on facilitated self selection of P medicines and GPhC's FAQs on self-selection and open display of Pharmacy medicines. (Please note: Edition 48 MEP does not contain signposting to RPS' position statement and pharmacy guide on facilitated self selection of P medicines as these were published after printing of the book).
Updated the reference to veterinary regulations to the Veterinary Medicines (Amendment etc.) Regulations 2024.
Added information on and signposting to the RPS Greener Pharmacy Toolkit.
Added information on and signposting to the RPS RCGP Repeat Prescribing Toolkit.
Added information on RPS’ position on structured and supported verification of medicines by pharmacy technicians in specialised settings and signposted to the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines.
Removed information and diagram on the NHS Just Culture guide and replaced with information and signposting to the new NHS Being fair tool: Supporting staff following a patient safety incident.
Added guidance and signposting to resources on remote prescribing.
Included information and signposting to the GPhC and PDA jointly produced article Using social media platforms professionally.
We have added GPhC's Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet to the appendices as appendix 10.
Updated to include signposting to the new GPhC standards on Chief Pharmacists
Included guidance on new legislation for original pack dispensing which came into force on 1 January 2025 allowing NHS community pharmacists to dispense up to 10% more or less than the quantity prescribed of eligible medicines on NHS prescriptions.
Updated with the change in legislation from 2nd December 2024 to allow more organisations and registered healthcare professionals to to supply naloxone for future use (‘take home’ naloxone) to those who need it, without a prescription.
Updated section to include details of the PPP status categories for isotretinoin and how this determines the treatment duration and monitoring requirements. Signposting to useful MHRA guidance such as the prescriber and pharmacist checklists and manufacturers SPCs Included signposting to the MHRA pregnancy prevention programme for topiramate (Topamax).
Guidance on pharmacists in research and research ethics has been removed from the MEP. Comprehensive information on this can be viewed on the RPS website www.rpharms.com.